Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SAGE | Common Stock | Options Exercise | $2.23K | +1.64K | +2.39% | $1.36* | 70.4K | Jan 2, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SAGE | Stock Option (Right to Buy) | Options Exercise | $0 | -1.64K | -100% | $0.00* | 0 | Jan 2, 2024 | Common Stock | 1.64K | $1.36 | Direct | F1 |
Id | Content |
---|---|
F1 | The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 23, 2016. |